<?xml version="1.0" encoding="utf-8" ?>
<?xml-stylesheet href="http://www.the-infoshop.com/rss/style.xsl" type="text/xsl" media="screen"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xml:lang="en">
<channel rdf:about="http://www.the-ifoshop.com/bio.shtml">
  <title>Biotechnology Market Research Reports | the-infoshop.com</title>
  <link>http://www.the-ifoshop.com/bio.shtml</link>
  <description>Biotechnology Market Research Reports </description>
  <dc:publisher>Global Information, Inc.</dc:publisher>
  <dc:rights>(C) 2008 Global Information, Inc.</dc:rights>
  <dc:date>2008-07-23</dc:date>
  <sy:updatePeriod>daily</sy:updatePeriod>
  <items>
    <rdf:Seq>
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fuji70647-sequencing.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/sb70562-cancer.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tak70563-molecular-diagno.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fuji70564-mono-antibody.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es70415-biopharma.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk70123-pcr-markets.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk70128-stem-cell.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd70599-cancer-bioma.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd70600-medical-need.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc63238-dna-diagnostics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti70112-wound-healing.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs70241-labo-info.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti70247-snp-detection.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs70268-microbiology-test.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti70270-cancer-thera.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti70308-detection-tech.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit70321-in-biotechno.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti70388-biology.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs69888-eu-drug-deli.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fd68527-enzymes.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rnc69056-biotech-india.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/koan69484-tissue-implant.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs69154-european-ivd.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rb69059-drug-delivery.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs68882-point-of-care.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dc68837-antibodies.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr68537-opportunities.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs68556-lung-cancer.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/wild67664-clinical-stage.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rb67670-contract.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg68552-antibodies.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/amid66901-cn-cephalosporin.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl68513-companion.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl68514-snp-genotyping.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rnc67054-vitro-diagnostic.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs67232-membr-bioreactor.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit70319-bio-nanotechno.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit70322-prions.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit70327-bioimaging.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit63060-stem-cell.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/labd68134-japan-drug.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr68442-cardiovascular.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl65934-ivd.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk66629-genomics-mkt.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es66919-orthobiologics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs66647-antibodies.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs66649-amplification.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/labd66589-diagnostics-ind.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/sb65946-epigenetics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk66628-diagno-testing.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk66630-rna-interfere.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/koan68421-tissue.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd69144-brain-barrier.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd69145-cardiotoxicity.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd69146-systems-biology.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/sb69333-diagnostics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/labd65801-drug-delivery.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs65336-pharma-biotech.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/wild65276-biopharma.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg66297-antibodies.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg66300-oncology.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg66305-immunotherapy.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg66333-protein.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/burr66553-2020-vision.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rb64802-convergence.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fuji64827-drug-rd.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/heal65560-perso-medicine.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs64704-heart-valve.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/wild64495-biopharma.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cei59693-postmarket.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk51838-testing-world.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk63076-diagnoses.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk63078-medicine.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl64387-biogenerics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg64862-therapeutics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk70127-point-of-care.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti64483-metabolomics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti64711-apoptosis.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit65878-chiral-chemicals.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti66421-adhesives.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es66457-biogen.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/mrg70421-asia-dental.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti66250-theranostics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fd64218-drug-delivery.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/labd59933-diagnostics-mkt.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs63994-cell-based-assays.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dc64547-biologics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dc64549-stakeholder.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr63869-pharmacogenomics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr63870-monoclonal.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg63840-anti-angiogenic.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/yd63673-biomems.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd63571-micrornas.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bf63299-increase-sales.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs63832-research-elisa.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs64756-molecular-poc.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rb63297-therapeutics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs63214-flow-cytometry.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs63218-blood-gas.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/go9627_seeds.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/go10980_laboratory_chemical.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/go15206_biotechnology.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/go25518_collagen.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/go63822-organ-and-tissue.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/go63824-biotechnology.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk63077-cancer-cell.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk63079-diagnostics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/pf63278-stem-cells.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl63279-cancer-diagno.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl63280-congestive.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rb64437-biotechnology.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rb64439-healthcare-policy.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es51223-sciences.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr63267-validation.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit62972-dna-sequencing.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc62644-rna-interfere.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd62653-multiplex-assays.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs62687-biopsy.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs62332-mass-spectrometry.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg62356-apoptopic-drug.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd62858-epigenetics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg63562-lung-cancer.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg63563-apoptopic-drugs.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/wild60336-biopharma.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rnc60386-insulin-delivery.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl60581-china-molecular.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs61911-assays-markets.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bf63300-life-sciences.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc63668-forensic-tech.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc63669-reagents.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc63671-electropho-tech.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr60590-rnai.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bph62219-cancer-stem.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bph62220-neuropathy.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bph62222-drug-resistance.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit62969-rnai-mkt-insight.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit63054-herg-screening.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit63056-adme-tox.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit63057-high-throughput.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit63058-biomarkers.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit63059-metabolomics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit63068-apoptosis.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rit63070-implants.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc60393-environmental.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc60394-companion.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bf60347-life-scientists.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd60107-molecular-imaging.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs59651-immunochemicals.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs59653-molecular-imaging.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/sb59572-microrna2008.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kt64574-live-licensing.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs59050-eu-immunochemistry.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs58989-biopharmaceutical.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dc60126-stakeholder.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fuji58910-dna-diagnostic.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/wild58808-co-marketing.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/rb62226-bioinformatics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti59036-infections.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/ti59065-synthetic-biology.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/sb60568-immunoassays.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/mrg64510-us-biomaterials.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/mrg64512-biomaterials.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/go47247-organs.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dc58749-autoimmune.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc58557-healthcare.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs58497-us-cardiac.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs58499-biotechnology.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk56795-clinical-chemistry.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/tk58612-clinical-immun.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr56532-diagnostics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr58446-alzheimer-dis.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr58548-next-generation.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr56533-licensing.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg58772-antibody-drug.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bf58167-exploring-cn-in.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd58119-therapeutic.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl58996-gene-express.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es17860_recordati_pharma.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd58120-molecular.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/sb58163-therapeutics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/mrg63087-soft-tissue.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/mrg63103-soft-tissue.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dm58089-biotherapeutics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/dr56476-biogenerics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/fs57997-purification.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc57874-biomarkers.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es57909-drug-delivery.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es57910-prospects.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es57911-drug-delivery.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es57912-nucleic-acid.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/es57913-drug-delivery.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bg58166-antibody-drug.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/wild57469-biopharma.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl57497-diagnostics.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/kl57498-analytical-chip.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc57920-drug-discovery.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bc58140-biomedical-pharm.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/koan58408-hip-implant.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/bf57134-life-science.html" />
      <rdf:li rdf:resource="http://www.the-infoshop.com/study/cd57284-antibodies.html" />

    </rdf:Seq>
  </items>
</channel>

<item rdf:about="http://www.the-infoshop.com/study/fuji70647-sequencing.html">
  <dc:language>en</dc:language>
  <dc:date>2008-07-22</dc:date>
  <dc:creator>Fuji-Keizai U.S.A., Inc.</dc:creator>
  <title>Next Generation Sequencing for Life Science R&amp;D: Advancing to the $1,000 Genome</title>
  <link>http://www.the-infoshop.com/study/fuji70647-sequencing.html</link>
  <description>This report examines the emerging, fast-growing worldwide market for next-generation genome sequencing systems and services.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/sb70562-cancer.html">
  <dc:language>en</dc:language>
  <dc:date>2008-07-16</dc:date>
  <dc:creator>Select Biosciences, Ltd.</dc:creator>
  <title>Cancer Personalized Medicine 2008</title>
  <link>http://www.the-infoshop.com/study/sb70562-cancer.html</link>
  <description>This report provides Cancer Personalized Medicine Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tak70563-molecular-diagno.html">
  <dc:language>en</dc:language>
  <dc:date>2008-07-16</dc:date>
  <dc:creator>Takeda Pacific</dc:creator>
  <title>Commercializing Molecular Diagnostics: Products,Services,Companies and Global Market</title>
  <link>http://www.the-infoshop.com/study/tak70563-molecular-diagno.html</link>
  <description>This report discusses government regulatory initiatives to accelerate the approvals of emerging molecular diagnostics by integrating biomarkers and companion pharmacogenomic tests. Myriad, Veridex, Genomic Health, Agendia and others are gaining traction detecting cancers. Roche' s Affymetrix-based tests measure how patients respond to 30 or more currently marketed drugs. These products enable the emerging field of personalized medicine. The passing of the GINA law in the US might foster the growth of more molecular diagnostics, clinical lab services and other related genetic testing services.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fuji70564-mono-antibody.html">
  <dc:language>en</dc:language>
  <dc:date>2008-07-14</dc:date>
  <dc:creator>Fuji-Keizai U.S.A., Inc.</dc:creator>
  <title>U.S. and Worldwide Monoclonal Antibody Medicine</title>
  <link>http://www.the-infoshop.com/study/fuji70564-mono-antibody.html</link>
  <description>This report analyzes the activities of the leading biopharmaceutical companies with antibody-based drug products currently on the market or scheduled for introduction soon. The focus is MAb therapeutics used for treating a disease or condition (as opposed to MAbs used as a diagnostic or for research). The report details the status of drug makers' antibody pipelines; their alliances, M&amp;As and investments to develop and commercialize new MAb drugs; and their standing in the battle for market share and bringing a new best-selling drug to patients. Technological progression in the development of antibody and protein-based human therapies is overviewed. This report is part of Fuji-Keizai' s ongoing efforts to track the U.S. and global biopharmaceuticals marketplace.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/es70415-biopharma.html">
  <dc:language>en</dc:language>
  <dc:date>2008-07-04</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Biopharmaceuticals in South East Asia: Setting sights on global leadership</title>
  <link>http://www.the-infoshop.com/study/es70415-biopharma.html</link>
  <description>This detailed report analyses the market and research environments, assessing risk and identifying opportunity in Indonesia, Malaysia, Singapore, South Korea, Taiwan and Thailand.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk70123-pcr-markets.html">
  <dc:language>en</dc:language>
  <dc:date>2008-07-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>DNA Sequencing and PCR Markets</title>
  <link>http://www.the-infoshop.com/study/tk70123-pcr-markets.html</link>
  <description>The focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk70128-stem-cell.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine Market Research</dc:subject>
  <dc:date>2008-07-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Stem Cell Markets</title>
  <link>http://www.the-infoshop.com/study/tk70128-stem-cell.html</link>
  <description>A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd70599-cancer-bioma.html">
  <dc:language>en</dc:language>
  <dc:date>2008-07-01</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>Cancer Biomarkers: Adoption Is Driving Growth</title>
  <link>http://www.the-infoshop.com/study/cd70599-cancer-bioma.html</link>
  <description>Cancer Biomarkers: Adoption Is Driving Growth explores the various applications for cancer biomarkers across the healthcare spectrum by presenting the successful adoption of specific biomarkers. These applications include the identification of novel therapeutic targets in cancer drug discovery and uses of cancer biomarkers as surrogate markers for drug efficacy in clinical trials. This report describes a number of factors providing the driving forces behind cancer biomarker growth and commercialization. These factors include requirements to improve screening and early detection, to provide better guidance on therapy and the need to avoid therapy resistance attributes, for understanding cancer staging, response to treatment, and prognosis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd70600-medical-need.html">
  <dc:language>en</dc:language>
  <dc:date>2008-07-01</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>Antibiotic R&amp;D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive</title>
  <link>http://www.the-infoshop.com/study/cd70600-medical-need.html</link>
  <description>The current crisis in antibiotic R&amp;D is attributed to an industry pipeline with few late-stage candidates capable of combating the emergence and spread of novel, drug-resistant bacterial strains.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bc63238-dna-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>DNA Diagnostics: Technologies and Global Markets</title>
  <link>http://www.the-infoshop.com/study/bc63238-dna-diagnostics.html</link>
  <description>This report provides Global DNA Diagnostics Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti70112-wound-healing.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Advances in Wound Healing Techniques</title>
  <link>http://www.the-infoshop.com/study/ti70112-wound-healing.html</link>
  <description>This research service provides the latest trends in wound healing techniques and future developments.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs70241-labo-info.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Strategic Analysis of U.S. Laboratory Information Management Systems (LIMS) Markets</title>
  <link>http://www.the-infoshop.com/study/fs70241-labo-info.html</link>
  <description>This research service provides a strategic analysis of laboratory information management system markets within the United States. The research service covers market trends, technology trends, competitive structure, market share analysis, and revenue forecasts. The key challenges and strategies are covered for the total market overview.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti70247-snp-detection.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Technologies for SNP Detection and Mapping</title>
  <link>http://www.the-infoshop.com/study/ti70247-snp-detection.html</link>
  <description>This research service analyzes the global trends in the SNP detection and mapping with a focus on the current and prospective applications of these variations.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs70268-microbiology-test.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Rapid Microbiology Tests Markets</title>
  <link>http://www.the-infoshop.com/study/fs70268-microbiology-test.html</link>
  <description>This research service analyzes the market for rapid microbiology tests within the United States. The market was divided into the three segments. Each segment covers market trends, technology trends, competitive structure, market share analysis and revenue forecasts. The key challenges and strategies are covered for the total market overview.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti70270-cancer-thera.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals)</title>
  <link>http://www.the-infoshop.com/study/ti70270-cancer-thera.html</link>
  <description>This research service analyzes the emerging trends in cancer therapies with respect to small molecule drugs and biologicals.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti70308-detection-tech.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Advances in Label-Free Detection Technologies</title>
  <link>http://www.the-infoshop.com/study/ti70308-detection-tech.html</link>
  <description>This research service outlines the key developments taking place globally and emerging trends in the field of label-free technologies for drug discovery applications.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit70321-in-biotechno.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>BIOTECHNOLOGY IN INDIA - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit70321-in-biotechno.html</link>
  <description>This market insight report on Biotechnology covers products, technologies and services used in the Indian Biotechnology Industry. The report studies the BioAgriculture and BioIndustry market in detail. Market projections and estimates are illustrated by sector and by technology. The Bio Agriculture sector is segmented into BioPesticides and BioFertilizers; and the Bio Industry sector is segmented into Fermentation Products, BioFuels and BioPolymers. Major Biopharmaceutical, Biofuels, Bioinformatics companies and Contract Research Organisations serving the industry are also covered in the report.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti70388-biology.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-06-30</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Emerging Technologies in Systems Biology</title>
  <link>http://www.the-infoshop.com/study/ti70388-biology.html</link>
  <description>This research service analyzes the global trends in the systems biology with a focus on the current and prospective applications of this platform.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs69888-eu-drug-deli.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-26</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Drug Delivery Markets - Opportunity Analysis</title>
  <link>http://www.the-infoshop.com/study/fs69888-eu-drug-deli.html</link>
  <description>The research services deals with the a strategic insight in to the opportunity in the drug delivery markets especially pulmonary and transdermal segments in Europe. Market drivers, restraints, industry challenges, key trends, revenue forecasts and strategic recommendations are provided in detail.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fd68527-enzymes.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-25</dc:date>
  <dc:creator>The Freedonia Group</dc:creator>
  <title>Enzymes (US industry forecasts for 2012 &amp; 2017)</title>
  <link>http://www.the-infoshop.com/study/fd68527-enzymes.html</link>
  <description>It presents historical demand data plus forecasts for 2012 and 2017 by market and product.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rnc69056-biotech-india.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-25</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Booming Biotech Market in India</title>
  <link>http://www.the-infoshop.com/study/rnc69056-biotech-india.html</link>
  <description>The report provides comprehensive information on the market size, structure, domestic consumption, exports, key segments, investment, manpower, market share of key players, drivers, restraints and present and future trends of the biotechnology market in India.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/koan69484-tissue-implant.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials Market Research</dc:subject>
  <dc:subject>Regenerative Medicine Market Research</dc:subject>
  <dc:date>2008-06-25</dc:date>
  <dc:creator>Koncept Analytics</dc:creator>
  <title>Market for Tissue Implant Applications</title>
  <link>http://www.the-infoshop.com/study/koan69484-tissue-implant.html</link>
  <description>The whole process of tissue implant starts from the donor to the processing unit and then finally reaching the hospitals or the patients. The players in this industry are manufacturers, distributors, medical technology companies. Few of the major players are LifeCell, Stryker, and Synthes.     This report covers the tissue implant market. It discusses the types of tissues, sources and distribution chain. It also talks about the various surgical procedures or markets like spine, trauma where tissue implants are being used. It discusses the regulatory environment covering this market, the growth drivers and the competitive landscape.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs69154-european-ivd.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-18</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Western European IVD Markets</title>
  <link>http://www.the-infoshop.com/study/fs69154-european-ivd.html</link>
  <description>This Frost &amp; Sullivan research service titled Western European IVD Markets provides an overview of the IVD markets in Europe, together with the revenues for each market.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rb69059-drug-delivery.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-16</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments</title>
  <link>http://www.the-infoshop.com/study/rb69059-drug-delivery.html</link>
  <description>Over the last decade, the drug delivery industry has evolved to become a key area in the development of value added pharmaceutical products.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs68882-point-of-care.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-10</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Point-of-Care Connectivity Markets</title>
  <link>http://www.the-infoshop.com/study/fs68882-point-of-care.html</link>
  <description>This research service analyes the market opportunities for POC connectivity solutions in major seven European countries like Germany, France, Italy, Spain, UK, Benelux and Scandinavia.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dc68837-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-06-06</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Monoclonal Antibodies Report: 2008 Update</title>
  <link>http://www.the-infoshop.com/study/dc68837-antibodies.html</link>
  <description>The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2013 and assessing trends by product, company, therapy area, technology and target type.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dr68537-opportunities.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-05</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>The Landscape of Companion Diagnostics: Challenges, Opportunities, and Future Trends</title>
  <link>http://www.the-infoshop.com/study/dr68537-opportunities.html</link>
  <description>Diagnostics can be used to identify subgroups of patients who may or may not benefi t from a companion drug, who may have adverse reactions to that drug, or who may require different doses of that drug because of their particular metabolic activity.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs68556-lung-cancer.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-05</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Lung Cancer Therapeutics Markets</title>
  <link>http://www.the-infoshop.com/study/fs68556-lung-cancer.html</link>
  <description>This research service analyses the European Lung cancer therapeutics market. It analyses market drivers, restraints and challenges faced by industry participants. Revenue forecasts and pipeline analysis has been discussed. It also provides strategic recommendations.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/wild67664-clinical-stage.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-03</dc:date>
  <dc:creator>CurrentPartnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Clinical Stage Partnering Agreements in Biopharma</title>
  <link>http://www.the-infoshop.com/study/wild67664-clinical-stage.html</link>
  <description>The report provides a detailed understand and analysis of how and why companies enter clinical stage partnering deals.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rb67670-contract.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-03</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>Contract Manufacturing Strategies: Market developments, technology transfer and key success factors</title>
  <link>http://www.the-infoshop.com/study/rb67670-contract.html</link>
  <description>Drug manufacture now typically accounts for 25% of company revenues and achieving agility in the manufacturing process has become essential for pharma companies hoping to align their supply chains with constant shifts in global product demand.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg68552-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-06-03</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Cancer Antibodies: Competitive Positioning for Success</title>
  <link>http://www.the-infoshop.com/study/bg68552-antibodies.html</link>
  <description>This report aims to analyze the current and future potential of cancer antibodies by examining key fundamentals across the entire pipeline of antibody drug candidates.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/amid66901-cn-cephalosporin.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-06-01</dc:date>
  <dc:creator>Asia Market Information &amp; Development Co.</dc:creator>
  <title>Chinese Markets for Cephalosporins</title>
  <link>http://www.the-infoshop.com/study/amid66901-cn-cephalosporin.html</link>
  <description>China' s demand for Cephalosporins has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1997, 2002 and 2007) and long-term forecasts throught 2012 and 2017 are presented. Major producers in China are profiled.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/kl68513-companion.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine)</title>
  <link>http://www.the-infoshop.com/study/kl68513-companion.html</link>
  <description>This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/kl68514-snp-genotyping.html">
  <dc:language>en</dc:language>
  <dc:date>2008-06-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>SNP Genotyping and Analysis Markets</title>
  <link>http://www.the-infoshop.com/study/kl68514-snp-genotyping.html</link>
  <description>This report provides SNP Genotyping Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rnc67054-vitro-diagnostic.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-30</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Global In Vitro Diagnostic Market Analysis</title>
  <link>http://www.the-infoshop.com/study/rnc67054-vitro-diagnostic.html</link>
  <description>The In Vitro Diagnostics (IVD) Industry represents one of the most lucrative segments in global healthcare industry.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs67232-membr-bioreactor.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-30</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Global Membrane Bioreactor Markets</title>
  <link>http://www.the-infoshop.com/study/fs67232-membr-bioreactor.html</link>
  <description>This market snapshot global research service looked at the Membrane Bioreactor systems market in Europe, North &amp; South America, Asia Pacific, Middle East and Africa. A regional market profile was provided, which included a review of the membrane bioreactor market in each region, analysing the key market forces of drivers and restraints, market measurements of market size for base year, corresponding annual growth rate including the compound annual growth rate for the forecast period and the revenue share trends by the two major application segments of municipal and industrial sectors.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit70319-bio-nanotechno.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-30</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>BIO NANOTECHNOLOGY - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit70319-bio-nanotechno.html</link>
  <description>The Bionanotechnology Market Insight Report studies the impact of Nanotechnology in various Biotechnology applications. The study focuses on major Applications including Food, Drug Discovery and Delivery, Diagnostics, Device and Tools, and Bionanosensors.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit70322-prions.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-30</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>PRIONS - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit70322-prions.html</link>
  <description>Prions report gives an insight into the market for Prion Deactivation technologies, Post Mortem Testing for BSE and Prion Reduction Filters.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit70327-bioimaging.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-30</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>BIOIMAGING - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit70327-bioimaging.html</link>
  <description>The study provides global market analysis for bioimaging by Type (Medical and Molecular) and Modalities including Ultrasound, CT, MRI, PET, SPECT and other modalities comprising X-Ray, TEM and OCT.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit63060-stem-cell.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine Market Research</dc:subject>
  <dc:date>2008-05-29</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>STEM CELL RESEARCH - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit63060-stem-cell.html</link>
  <description>This report analyzes the prevalent Stem Cell technologies and the therapeutic areas in which stem cells find applications.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/labd68134-japan-drug.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-29</dc:date>
  <dc:creator>Global Markets Direct</dc:creator>
  <title>Japan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012</title>
  <link>http://www.the-infoshop.com/study/labd68134-japan-drug.html</link>
  <description>This report is an essential source for in-depth information and data relating to the Japan Drug Delivery Devices devices market.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dr68442-cardiovascular.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-28</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Blood Biomarkers and Beyond: Biomarker and Diagnostic Opportunities in Cardiovascular Disease</title>
  <link>http://www.the-infoshop.com/study/dr68442-cardiovascular.html</link>
  <description>Demographic and cost data provide clear reasons for pharmaceutical industry investment in CVD biomarkers and diagnostics.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/kl65934-ivd.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-21</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition</title>
  <link>http://www.the-infoshop.com/study/kl65934-ivd.html</link>
  <description>This completely updated edition of Kalorama' s comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk66629-genomics-mkt.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-05-15</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Genomics World Markets</title>
  <link>http://www.the-infoshop.com/study/tk66629-genomics-mkt.html</link>
  <description>Genomics is transforming the pharmaceutical industry. Companies are moving from drug discovery and development based on medicinal chemistry to the design of drugs based on information provided by genomics. Virtually all of the major pharmaceutical houses have either formed partnerships with genomics firms that began to emerge in the early 1990s or have created in house genomics divisions. The aim of this TriMark Publications study is to provide in depth information on the developing market for genomics products and services.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/es66919-orthobiologics.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine Market Research</dc:subject>
  <dc:date>2008-05-14</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>The Global Orthobiologics Market</title>
  <link>http://www.the-infoshop.com/study/es66919-orthobiologics.html</link>
  <description>This report provides extensive competitive comparison and evaluation of major and emerging companies in the orthobiologics market covering key sectors: alllograft tissue, demineralised bone matrix, growth factors, synthetic bone graft, stem cell therapy, joint fluid therapy and cartilage repair.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs66647-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-05-13</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Biotechnology - Therapeutic Monoclonal Antibodies Market</title>
  <link>http://www.the-infoshop.com/study/fs66647-antibodies.html</link>
  <description>This research service covers the U.S. biotechnology: therapeutic monoclonal antibodies market from 2004-2014. Included are a disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs66649-amplification.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-12</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Nucleic Acid-based Amplification Reagents Markets for Clinical Applications</title>
  <link>http://www.the-infoshop.com/study/fs66649-amplification.html</link>
  <description>This research service gives a detailed analysis of the NAT reagents market for clinical applications in Europe from 2004-2014</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/labd66589-diagnostics-ind.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-02</dc:date>
  <dc:creator>Global Markets Direct</dc:creator>
  <title>United States In Vitro Diagnostics Industry Report</title>
  <link>http://www.the-infoshop.com/study/labd66589-diagnostics-ind.html</link>
  <description>This report is an essential source for in-depth information and data relating to the USA In Vitro Diagnostics devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the In Vitro Diagnostics in USA</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/sb65946-epigenetics.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapy Market Research</dc:subject>
  <dc:date>2008-05-01</dc:date>
  <dc:creator>Select Biosciences, Ltd.</dc:creator>
  <title>Epigenetics and MicroRNA Diagnostics/Therapeutics 2008</title>
  <link>http://www.the-infoshop.com/study/sb65946-epigenetics.html</link>
  <description>This is the latest Epigenetics and MicroRNA Diagnostics/Therapeutics Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the Epigenetics Marketplace based upon our continuing industry coverage.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk66628-diagno-testing.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-05-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Cardiac Marker Diagnostic Testing Markets</title>
  <link>http://www.the-infoshop.com/study/tk66628-diagno-testing.html</link>
  <description>The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing. This study examines clinical measurement devices and their reagents and supplies as used in hospitals, clinics and doctor' s offices. This examination is arranged to provide the reader with an overview of the outstanding diagnostic test market segments of cardiac care, with evidence that these segments are poised for high future growth.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk66630-rna-interfere.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapy Market Research</dc:subject>
  <dc:date>2008-05-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>RNA Interference Markets</title>
  <link>http://www.the-infoshop.com/study/tk66630-rna-interfere.html</link>
  <description>This study defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence market size and growth for RNAi testing. The main objectives of this study are to: 1) understand the different sectors of RNAi testing market and to look at a description of the instruments, reagents and supplies marketed by major companies in each segment; 2) obtain a complete understanding of the individual RNAi-testing platforms-from basic principles to clinical applications; 3) discover feasible market opportunities by identifying high-growth applications in different analytical diagnostic areas, with a focus on the biggest and expanding markets; 4) focus on global industry developments and trends through an in-depth analysis of the major world markets for RNAi measurement technology, including growth forecasts; and 5) present market figures related to the current value of RNAi testing, market projections, market share, key players and sector growth rates.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/koan68421-tissue.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine Market Research</dc:subject>
  <dc:date>2008-05-01</dc:date>
  <dc:creator>Koncept Analytics</dc:creator>
  <title>Worldwide Heart Valve Market: Focus on Tissue Valves</title>
  <link>http://www.the-infoshop.com/study/koan68421-tissue.html</link>
  <description>The report is aimed at providing a basic understanding of the heart valve market. It analyzes the worldwide and US market.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd69144-brain-barrier.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-01</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>Blood-Brain Barrier: Bridging Options for Drug Discovery and Development</title>
  <link>http://www.the-infoshop.com/study/cd69144-brain-barrier.html</link>
  <description>CNS diseases are a major focus of the pharmaceutical industry, with CNS drugs representing some of its most successful products. These include Pfizer' s Zoloft (sertraline, for treatment of depression and certain types of anxiety disorders), Lilly' s Cymbalta (duloxetine, for treatment of depression) and Bristol-Myers Squibb' s/Otsuka' s Abilify (aripiprazole, for treatment of bipolar disorder and schizophrenia). However, drug discovery and development researchers experience difficulty developing CNS drugs that complete clinical trials and win regulatory approval - especially drugs which meet major unmet needs in the CNS area, such as Alzheimer' s disease. The vast majority of drugs fail to cross the BBB, which is causing a major bottleneck in successful development of CNS drug candidates.     This report reviews the discovery, design and development of small- and large-molecule drugs that can efficiently cross the BBB. This includes more traditional, medicinal chemistry-based methods, as well as approaches that exploit carrier-mediated transport (CMT) and receptor-mediated transport (RMT). Also covered in the report is use of nanoparticle technology to enable BBB penetration. Further, the report presents in vitro and in vivo assays as well as imaging methods to ascertain a drug' s ability to cross the BBB and reach its target.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd69145-cardiotoxicity.html">
  <dc:language>en</dc:language>
  <dc:date>2008-05-01</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>Cardiotoxicity: Issues, Technologies, and Solutions for the Future</title>
  <link>http://www.the-infoshop.com/study/cd69145-cardiotoxicity.html</link>
  <description>At least 50 companies have a claimed product or service relevant to cardiotoxicity screening, of which 29 have some clear focus on proarrhythmic cardiotoxicity or ion channel screening.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd69146-systems-biology.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-05-01</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>Systems Biology: A Disruptive Technology</title>
  <link>http://www.the-infoshop.com/study/cd69146-systems-biology.html</link>
  <description>This report focuses on the current and future applications of Systems Biology in drug discovery, specifically in pinpointing optimal individual targets, and combinations of targets, to overcome metabolic pathway redundancies, leading to efficacious and safe products.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/sb69333-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-05-01</dc:date>
  <dc:creator>Select Biosciences, Ltd.</dc:creator>
  <title>Multiplexed Diagnostics 2008 Market Report</title>
  <link>http://www.the-infoshop.com/study/sb69333-diagnostics.html</link>
  <description>This report provides Multiplexed Diagnostics Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/labd65801-drug-delivery.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-23</dc:date>
  <dc:creator>Global Markets Direct</dc:creator>
  <title>United States Drug Delivery Devices Medical Equipment Industry Report : Detailed Analysis of the Medical Equipment &amp; Medical Devices Market Covering Infusion Systems, Inhalation Systems and Needle Free Injections Medical Equipment and Supplies</title>
  <link>http://www.the-infoshop.com/study/labd65801-drug-delivery.html</link>
  <description>This report is an essential source for in-depth information and data relating to United States drug delivery devices medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices medical equipment in United States.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs65336-pharma-biotech.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-22</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Pharma/Biotech Contract Manufacturing Markets: A Strategic Outlook</title>
  <link>http://www.the-infoshop.com/study/fs65336-pharma-biotech.html</link>
  <description>This research service provides a strategic outlook of the pharma/Biotech contract manufacturing markets in Europe.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/wild65276-biopharma.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-21</dc:date>
  <dc:creator>CurrentPartnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Manufacturing and Supply Agreements in Biopharma</title>
  <link>http://www.the-infoshop.com/study/wild65276-biopharma.html</link>
  <description>The report provides a detailed understand and analysis of how and why companies enter manufacturing and supply deals.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg66297-antibodies.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-04-20</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Antibodies in Oncology: Drug Pipeline Update 2008</title>
  <link>http://www.the-infoshop.com/study/bg66297-antibodies.html</link>
  <description>The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field of therapeutic antibodies.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg66300-oncology.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-20</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Apoptosis in Oncology: Drug Pipeline Update 2008</title>
  <link>http://www.the-infoshop.com/study/bg66300-oncology.html</link>
  <description>Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis of cancer cells.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg66305-immunotherapy.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-04-20</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Immunotherapy in Oncology: Drug Pipeline Update 2008</title>
  <link>http://www.the-infoshop.com/study/bg66305-immunotherapy.html</link>
  <description>Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg66333-protein.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-20</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2008</title>
  <link>http://www.the-infoshop.com/study/bg66333-protein.html</link>
  <description>Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/burr66553-2020-vision.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-19</dc:date>
  <dc:creator>BURRILL &amp; COMPANY</dc:creator>
  <title>Biotech 2008 - Life Sciences: A 20/20 Vision to 2020</title>
  <link>http://www.the-infoshop.com/study/burr66553-2020-vision.html</link>
  <description>2007 Industry Financials, including 12 months of company financial data and market caps for the US, Europe, Canada, and Asia</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rb64802-convergence.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-04-15</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends</title>
  <link>http://www.the-infoshop.com/study/rb64802-convergence.html</link>
  <description>This report provides Biomarkers &amp; Diagnostics Convergence Market Research ,Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fuji64827-drug-rd.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-11</dc:date>
  <dc:creator>Fuji-Keizai U.S.A., Inc.</dc:creator>
  <title>Biochip Trends for Drug R&amp;D and Diagnostics - Companies, Equipment, Consumables, Software, Services and World Market</title>
  <link>http://www.the-infoshop.com/study/fuji64827-drug-rd.html</link>
  <description>This report discusses new biochip products now reaching the market. DNA/ RNA products discussed include high-density tiling, copy number variation, SNPs, alternate splice variant, ChIP-Chip, CpG island, DNA methylation, microRNA, molecular diagnostic biochips and related areas such as sequencing.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/heal65560-perso-medicine.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-09</dc:date>
  <dc:creator>Health Industry Insights</dc:creator>
  <title>Payers on the Future of Personalized Medicine, Part 1: Getting Ready for Change</title>
  <link>http://www.the-infoshop.com/study/heal65560-perso-medicine.html</link>
  <description>This Health Industry Insights report identifies and discusses initial insights obtained from Health Industry Insights' 2007 Personalized Medicine Payer Survey regarding the adoption of personalized medicine (PM) in the United States.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs64704-heart-valve.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-08</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Heart Valve Repairs Markets in Europe</title>
  <link>http://www.the-infoshop.com/study/fs64704-heart-valve.html</link>
  <description>This research service seeks to forecast the heart valve repairs market in Europe.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/wild64495-biopharma.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-07</dc:date>
  <dc:creator>CurrentPartnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Distribution Agreements in Biopharma</title>
  <link>http://www.the-infoshop.com/study/wild64495-biopharma.html</link>
  <description>The report provides a detailed understand and analysis of how and why companies enter distribution deals.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cei59693-postmarket.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-03</dc:date>
  <dc:creator>Cutting Edge Information</dc:creator>
  <title>In Vitro Diagnostics: Development Through Postmarket</title>
  <link>http://www.the-infoshop.com/study/cei59693-postmarket.html</link>
  <description>Make the most of limited resources by benchmarking IVDs' budgets and staff support for development, marketing, reimbursement and sales.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk51838-testing-world.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-04-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Cancer Diagnostic Testing World Markets</title>
  <link>http://www.the-infoshop.com/study/tk51838-testing-world.html</link>
  <description>This report provides Cancer Diagnostic Testing World Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk63076-diagnoses.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-04-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Biomarker Technology Platforms for Cancer Diagnoses and Therapies</title>
  <link>http://www.the-infoshop.com/study/tk63076-diagnoses.html</link>
  <description>Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk63078-medicine.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Companion Diagnostics in Personalized Medicine and Cancer Therapy</title>
  <link>http://www.the-infoshop.com/study/tk63078-medicine.html</link>
  <description>A near-term market opportunity for cancer companion diagnostic tests exists in drug selection for cancer therapy. Co-development of molecular diagnostics and targeted therapeutics has already been proven to be a successful strategy in the development of novel anti-cancer drugs.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/kl64387-biogenerics.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>Biogenerics: The World Market for Biosimilars</title>
  <link>http://www.the-infoshop.com/study/kl64387-biogenerics.html</link>
  <description>This report provides Global Biogenerics Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg64862-therapeutics.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-04-01</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics</title>
  <link>http://www.the-infoshop.com/study/bg64862-therapeutics.html</link>
  <description>The discovery of new cancer therapeutics has seen a significant shift towards biologicals as an alternative to small molecule drugs.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk70127-point-of-care.html">
  <dc:language>en</dc:language>
  <dc:date>2008-04-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Point of Care Diagnostic Testing World Markets</title>
  <link>http://www.the-infoshop.com/study/tk70127-point-of-care.html</link>
  <description>The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics market called point of care testing (POCT).</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti64483-metabolomics.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-31</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Advances in Metabolomics</title>
  <link>http://www.the-infoshop.com/study/ti64483-metabolomics.html</link>
  <description>This research service analyzes the global trends in the metabolomics with a focus on the current and prospective applications of this platform.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti64711-apoptosis.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-31</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Advances in Apoptosis Research</title>
  <link>http://www.the-infoshop.com/study/ti64711-apoptosis.html</link>
  <description>This research service provides the latest trends in apoptosis research and future developments</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit65878-chiral-chemicals.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>Chiral Chemicals - A Market Insight Report</title>
  <link>http://www.the-infoshop.com/study/rit65878-chiral-chemicals.html</link>
  <description>This market insight report on Chiral Chemicals focuses on the different Methods and Applications of Chiral Chemicals. Various Chiral Chemical preparation and separation methods include Traditional, Asymmetric, Biological and Other.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti66421-adhesives.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-31</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Biobased Adhesives--The Trend of the Future</title>
  <link>http://www.the-infoshop.com/study/ti66421-adhesives.html</link>
  <description>This research service analyzes technology trends and developments in the field of biobased adhesives.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/es66457-biogen.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-31</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Biogen Idec: Pipeline, Products, Performance, Potential</title>
  <link>http://www.the-infoshop.com/study/es66457-biogen.html</link>
  <description>This new strategic analysis report provides a complete and critical review of the company and includes unique and independent assessments and forecasts of key products.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/mrg70421-asia-dental.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials Market Research</dc:subject>
  <dc:date>2008-03-31</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>Asia Pacific Markets for Dental Biomaterials 2008</title>
  <link>http://www.the-infoshop.com/study/mrg70421-asia-dental.html</link>
  <description>This market consists of dental bone graft substitutes (BGS), dental membranes, and tissue regeneration products.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti66250-theranostics.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-30</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Advances in Disease Theranostics</title>
  <link>http://www.the-infoshop.com/study/ti66250-theranostics.html</link>
  <description>This research service analyses the latest developments that has occurred in the field of theranostics, both from a technology and industry perspective.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fd64218-drug-delivery.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-28</dc:date>
  <dc:creator>The Freedonia Group</dc:creator>
  <title>Drug Delivery Systems</title>
  <link>http://www.the-infoshop.com/study/fd64218-drug-delivery.html</link>
  <description>This new Freedonia industry study, Drug Delivery Systems, presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 by type and application. The study also considers US market environment factors, evaluates company market share and profiles 43 industry competitors.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/labd59933-diagnostics-mkt.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-21</dc:date>
  <dc:creator>Global Markets Direct</dc:creator>
  <title>In Vitro Diagnostics Market Profile: Detailed Analysis of the Medical Equipment Market Covering Medical Devices, Biomedical Devices, Healthcare Appliances and Medical Supplies.</title>
  <link>http://www.the-infoshop.com/study/labd59933-diagnostics-mkt.html</link>
  <description>The report provides overview of key trends, drivers and restraints, future outlook, competitive landscape and key developments in the In Vitro Diagnostics market.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs63994-cell-based-assays.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-03-21</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Cell-Based Assays Markets</title>
  <link>http://www.the-infoshop.com/study/fs63994-cell-based-assays.html</link>
  <description>This study presents information on key research and drug discovery applications expected to influence the market, and highlights recent developments and product features that should be emulated by market participants to achieve corporate growth objectives.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dc64547-biologics.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-03-21</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Stakeholder Opinions: Biologics in Infectious Diseases - Well defined target populations are key to commercial success</title>
  <link>http://www.the-infoshop.com/study/dc64547-biologics.html</link>
  <description>This report provides Biologics in Infectious Diseases Stakeholder Opinions Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dc64549-stakeholder.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-20</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies</title>
  <link>http://www.the-infoshop.com/study/dc64549-stakeholder.html</link>
  <description>SLE is a chronic, life-long and potentially fatal autoimmune disease characterized by multiple system distress and unpredictable flares.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dr63869-pharmacogenomics.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-19</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>How to Get Ahead with Pharmacogenomics</title>
  <link>http://www.the-infoshop.com/study/dr63869-pharmacogenomics.html</link>
  <description>The blockbuster business model is, of course, still relevant to the pharmaceutical industry, but at the same time, companies must adopt technologies that will enable them to develop better drugs-value-added drugs that can command the prices capable of providing an acceptable return on investment for the companies that develop them.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dr63870-monoclonal.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-18</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Biologics Pipelines: Who Has the Next Promising Monoclonal Antibodies?</title>
  <link>http://www.the-infoshop.com/study/dr63870-monoclonal.html</link>
  <description>Monoclonal antibodies (MAbs) are very hot commodities in today' s pharmaceutical marketplace, and in recent years, the growth in the number of MAbs under development has far outpaced the growth of other types of drugs.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg63840-anti-angiogenic.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-17</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Competitive Insights to Anti-Angiogenic Drug R&amp;D in Oncology</title>
  <link>http://www.the-infoshop.com/study/bg63840-anti-angiogenic.html</link>
  <description>This report is written for you to identify your competition and understand which targeting strategies are at work within anti-angiogenic drug development in oncology.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/yd63673-biomems.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-13</dc:date>
  <dc:creator>Yole Developpement</dc:creator>
  <title>BioMEMS 2008</title>
  <link>http://www.the-infoshop.com/study/yd63673-biomems.html</link>
  <description>Microelectronics, which has led to the explosion of consumer electronics sales, could now bring its added value to the Life Science applications. The key challenge for microelectronics is to make complexity invisible and adapt it to the value chain and way of working of the life science industries</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd63571-micrornas.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapy Market Research</dc:subject>
  <dc:date>2008-03-11</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>MicroRNAs: Commercial Products on the Horizon</title>
  <link>http://www.the-infoshop.com/study/cd63571-micrornas.html</link>
  <description>With the first diagnostics set to debut within a year, the new research and development field of microRNAs is beginning to reveal its potential.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bf63299-increase-sales.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-10</dc:date>
  <dc:creator>BioInformatics, LLC</dc:creator>
  <title>Life Science Product Catalogs: Techniques to Increase Sales</title>
  <link>http://www.the-infoshop.com/study/bf63299-increase-sales.html</link>
  <description>This report examines what attracts scientists to print and online catalogs, what information they need, their preferred formats, and what guides their buying decisions.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs63832-research-elisa.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-10</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Research ELISA Markets</title>
  <link>http://www.the-infoshop.com/study/fs63832-research-elisa.html</link>
  <description>This research service analyzes the market for research ELISAs within the United States. The market was divided into the research ELISA kit and research ELISA development components segments.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs64756-molecular-poc.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-10</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>The Emerging European Molecular POC Testing Markets</title>
  <link>http://www.the-infoshop.com/study/fs64756-molecular-poc.html</link>
  <description>This Frost &amp; Sullivan research service titled The Emerging European Molecular POC Testing Markets analyses the POC molecular and infectious disease markets, their competitive structure and strategic viewpoint.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rb63297-therapeutics.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-07</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players</title>
  <link>http://www.the-infoshop.com/study/rb63297-therapeutics.html</link>
  <description>This report provides Targeted Therapeutics Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs63214-flow-cytometry.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-05</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Flow Cytometry Markets</title>
  <link>http://www.the-infoshop.com/study/fs63214-flow-cytometry.html</link>
  <description>This research service analyzes the market for flow cytometry within the United States. The market was divided into the two segments.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs63218-blood-gas.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-05</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Eastern European Blood Gas Analysers and Monitors Markets</title>
  <link>http://www.the-infoshop.com/study/fs63218-blood-gas.html</link>
  <description>This research service studies the blood gas analysers and monitors market in Eastern Europe with qualitative and quantitative perspective.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/go9627_seeds.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-02</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>SEEDS</title>
  <link>http://www.the-infoshop.com/study/go9627_seeds.html</link>
  <description>This report analyzes the worldwide markets for Seeds in Millions of US$. The major product segments analyzed are Grain Seeds, Vegetable Seeds, Oilseeds, Horticulture Seeds (Flower Seeds, &amp; Lawn/Grass Seeds), Fruit Seeds, and Miscellaneous (includes treated seeds, flax seeds, and noxious seeds).The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2001 through 2015.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/go10980_laboratory_chemical.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-02</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Laboratory Chemical Reagents</title>
  <link>http://www.the-infoshop.com/study/go10980_laboratory_chemical.html</link>
  <description>The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/go15206_biotechnology.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-02</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Agricultural Biotechnology</title>
  <link>http://www.the-infoshop.com/study/go15206_biotechnology.html</link>
  <description>This report analyzes the worldwide markets for Agricultural Biotechnology in Millions of US$. The specific product segments analyzed are Transgenic Seeds/Crops (Soybean, Corn, Cotton, &amp; Others (Includes Canola, Wheat, Rice, and Potato among Others), and Biopesticides. The report provides separate comprehensive analytics for the US, Canada, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/go25518_collagen.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-02</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>COLLAGEN AND HA-BASED BIOMATERIALS</title>
  <link>http://www.the-infoshop.com/study/go25518_collagen.html</link>
  <description>This report analyzes the worldwide markets for Collagen and HA-Based Biomaterials in Millions of US$.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/go63822-organ-and-tissue.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-02</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Organ And Tissue Transplantation</title>
  <link>http://www.the-infoshop.com/study/go63822-organ-and-tissue.html</link>
  <description>This report analyzes the worldwide markets for Organ And Tissue Transplantation by Number of Procedures.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/go63824-biotechnology.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-02</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Marine Biotechnology</title>
  <link>http://www.the-infoshop.com/study/go63824-biotechnology.html</link>
  <description>This report analyzes the worldwide markets for Marine Biotechnology in Millions of US$. The major product segments analyzed are Marine Biomaterials, Marine Bioactive Substances, and Others.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk63077-cancer-cell.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-03-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Cancer Cell Therapy Markets</title>
  <link>http://www.the-infoshop.com/study/tk63077-cancer-cell.html</link>
  <description>Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, leading to the removal or at least the inhibition of cancer cell proliferation.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk63079-diagnostics.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-01</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Molecular Diagnostics Markets</title>
  <link>http://www.the-infoshop.com/study/tk63079-diagnostics.html</link>
  <description>The technologies that constitute molecular diagnostics-first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels-are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/pf63278-stem-cells.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine Market Research</dc:subject>
  <dc:date>2008-03-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development</title>
  <link>http://www.the-infoshop.com/study/pf63278-stem-cells.html</link>
  <description>With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/kl63279-cancer-diagno.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>The Worldwide Market for Cancer Diagnostics, 3rd Edition</title>
  <link>http://www.the-infoshop.com/study/kl63279-cancer-diagno.html</link>
  <description>Who are the major players in testing for the number two killer in the world? What revenues can companies competing in this market expect in the next five years? How will the impact of trends such as an increased role of pharmacodiagnostics, the use of multiplex assays and a new emphasis on service products influence cancer diagnostics?</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/kl63280-congestive.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>Congestive Heart Failure: Major World Markets, Volume I: Pharmaceutical Management</title>
  <link>http://www.the-infoshop.com/study/kl63280-congestive.html</link>
  <description>This report provides World Congestive Heart Failure Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rb64437-biotechnology.html">
  <dc:language>en</dc:language>
  <dc:date>2008-03-01</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles</title>
  <link>http://www.the-infoshop.com/study/rb64437-biotechnology.html</link>
  <description>In recent years, the biopharmaceutical industry has emerged as one of the most important sectors in the Healthcare industry.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rb64439-healthcare-policy.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-03-01</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>Impact of Pharmacogenomics on Public Healthcare Policy: Educating patients, payors and healthcare providers</title>
  <link>http://www.the-infoshop.com/study/rb64439-healthcare-policy.html</link>
  <description>This report provides Public Healthcare Policy Pharmacogenomics Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/es51223-sciences.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-29</dc:date>
  <dc:creator>Espicom Business Intelligence</dc:creator>
  <title>Gilead Sciences: Pipeline, Products, Performance, Potential</title>
  <link>http://www.the-infoshop.com/study/es51223-sciences.html</link>
  <description>This report provides a full review of the company’s activities together with sales forecasts for key products to 2011.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dr63267-validation.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-29</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>How Overcoming the Challenge of Biomarker Validation Can Pay Off for Drug and Diagnostic Developers</title>
  <link>http://www.the-infoshop.com/study/dr63267-validation.html</link>
  <description>This report presents How Overcoming the Challenge of Biomarker Validation Can Pay Off for Drug and Diagnostic Developers.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit62972-dna-sequencing.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-28</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>DNA Sequencing - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit62972-dna-sequencing.html</link>
  <description>This market insight report presents an in depth analysis of DNA Sequencing market. The study emphasizes on the Methods of DNA Sequencing and Instruments/Software used in DNA Sequencing for applications in Medical Research, Agriculture &amp; Animal Husbandry, DNA Testing, and Forensics.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bc62644-rna-interfere.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapy Market Research</dc:subject>
  <dc:date>2008-02-20</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>RNA Interference in the Post-Genomic Era: Markets and Technologies</title>
  <link>http://www.the-infoshop.com/study/bc62644-rna-interfere.html</link>
  <description>The growth rate of the research and development tools market segment is forecast to be a robust 19.5% per year during the study period to reach $424.5 million in 2013.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd62653-multiplex-assays.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-20</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions</title>
  <link>http://www.the-infoshop.com/study/cd62653-multiplex-assays.html</link>
  <description>This report provides Translational Medicine Multiplex Assays Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs62687-biopsy.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-20</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Market for Biopsy Devices</title>
  <link>http://www.the-infoshop.com/study/fs62687-biopsy.html</link>
  <description>This research service examines the European market for biopsy devices in terms of the challenges faced by market participants, drivers, and restraints in the industry, the competitive structure, the revenue forecasts and market trends.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs62332-mass-spectrometry.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-02-08</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Opportunities for the European Mass Spectrometry Market in Clinical Applications</title>
  <link>http://www.the-infoshop.com/study/fs62332-mass-spectrometry.html</link>
  <description>This research service gives a detailed analysis of the Mass Spectrometry market in Europe from 2004-2014.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg62356-apoptopic-drug.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-06</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>The Drug Target Atlas of Apoptopic Drugs in Oncology</title>
  <link>http://www.the-infoshop.com/study/bg62356-apoptopic-drug.html</link>
  <description>In the report, BioSeeker reports on 90 unique drug target combinations, each comprised of a different collection or mix of individually defined targets, for 114 apoptopic drugs designed for the treatment of 48 different cancer indications. The highest degree of distinctiveness among apoptopic drugs is achieved by sorting each of them according to targeted cancer indication, drug target mix, and drug compound type. At the same time we are also identifying peer groups of drugs, that is, drugs we consider suitable for head-to-head comparison during drug development.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd62858-epigenetics.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapy Market Research</dc:subject>
  <dc:date>2008-02-06</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>Epigenetics: Technologies, Applications, and the Commercial Landscape</title>
  <link>http://www.the-infoshop.com/study/cd62858-epigenetics.html</link>
  <description>This report provides Epigenetics Technologies, Applications,&amp; Commercial Landscape Market Research ,Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg63562-lung-cancer.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-06</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Target Atlas of Apoptopic Drugs &amp; Focus on Lung Cancer &amp; Melanoma</title>
  <link>http://www.the-infoshop.com/study/bg63562-lung-cancer.html</link>
  <description>This is the report for professionals interested to grasp the field of apoptopic drug targets in oncology and at the same time have an extensive R&amp;D overview of lung cancer and melanoma.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bg63563-apoptopic-drugs.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-06</dc:date>
  <dc:creator>BioSeeker Group AB</dc:creator>
  <title>Target Atlas of Apoptopic Drugs and Focus on Breast &amp; Prostate</title>
  <link>http://www.the-infoshop.com/study/bg63563-apoptopic-drugs.html</link>
  <description>This is the report for professionals interested to grasp the field of apoptopic drug targets in oncology and at the same time have an extensive R&amp;D overview of breast- and prostate cancer.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/wild60336-biopharma.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-01</dc:date>
  <dc:creator>CurrentPartnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Merger and Acquisition Agreements in Biopharma</title>
  <link>http://www.the-infoshop.com/study/wild60336-biopharma.html</link>
  <description>The Merger and Acquisition Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&amp;A) agreements entered into by the worlds leading biopharma companies.     The report provides a detailed understand and analysis of how and why companies enter merger and acquisition deals. The majority of deals are acquisitions whereby the acquirer acquires the target company in a cash and/or equity transaction.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rnc60386-insulin-delivery.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-01</dc:date>
  <dc:creator>RNCOS E-Services Pvt. Ltd.</dc:creator>
  <title>Insulin Delivery Systems Market Analysis (2007-2010)</title>
  <link>http://www.the-infoshop.com/study/rnc60386-insulin-delivery.html</link>
  <description>The research report Insulin Delivery Systems Market Analysis (2007-2010) by RNCOS gives an exhaustive analysis on the global insulin market and various Insulin delivery methods. The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, needle-free injectors and inhalers. It also takes into account pros and cons of each device and gives a detailed analysis on their future prospects.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/kl60581-china-molecular.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-01</dc:date>
  <dc:creator>Kalorama Information</dc:creator>
  <title>Molecular Diagnostics in China</title>
  <link>http://www.the-infoshop.com/study/kl60581-china-molecular.html</link>
  <description>This report provides China Molecular Diagnostics Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs61911-assays-markets.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-02-01</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Cell Based Assays Markets</title>
  <link>http://www.the-infoshop.com/study/fs61911-assays-markets.html</link>
  <description>This research service gives a detailed analysis of the cell based assay market in Europe from 2004-2014.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bf63300-life-sciences.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-01</dc:date>
  <dc:creator>BioInformatics, LLC</dc:creator>
  <title>Conference &amp; Exhibit Strategies in the Life Sciences: What's Working Now</title>
  <link>http://www.the-infoshop.com/study/bf63300-life-sciences.html</link>
  <description>This report provides Life Sciences Conference &amp; Exhibit Strategies Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bc63668-forensic-tech.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Forensic Technologies: New and Growing Markets</title>
  <link>http://www.the-infoshop.com/study/bc63668-forensic-tech.html</link>
  <description>Technology advancements in forensics have been of considerable import in recent years. Recent examples include improved fingerprint recovery from metals, such as gun cartridges and bomb fragments, use of the chemistry of color to identify chemical and biological weapons, and sensing technologies that are improving the detection of drugs and explosives at security checkpoints. Other advancements include portable DNA profiling techniques used at crime scenes, greater accuracy in ascertaining the age at death of victims of crime, and developments in scanning     These technological advancements have reduced per unit costs in practical applications, thus enhancing the affordability of forensic applications and increasing their market penetration.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bc63669-reagents.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Reagents for Chromatography</title>
  <link>http://www.the-infoshop.com/study/bc63669-reagents.html</link>
  <description>The overview of types of reagents and different techniques of chromatography is also examined along with sale figures over the 5-year period from 2007 to 2012. Companies selling the reagents of chromatography are profiled, and the factors affecting markets for these products and how those markets are likely to change are analyzed. Revenues have been broken down by the type of reagents and the usage of these reagents.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bc63671-electropho-tech.html">
  <dc:language>en</dc:language>
  <dc:date>2008-02-01</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Electrophoresis Technology: Global Markets</title>
  <link>http://www.the-infoshop.com/study/bc63671-electropho-tech.html</link>
  <description>The current market status for electrophoresis technology, with trends and forecasts for growth over the next 5 years</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dr60590-rnai.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>Decision Resources, Inc.</dc:creator>
  <title>Realizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi Delivery</title>
  <link>http://www.the-infoshop.com/study/dr60590-rnai.html</link>
  <description>The discovery of RNA interference (RNAi) has renewed interest in developing nucleic acid drugs based on targeting messenger RNAs (mRNAs). This fi eld of research offers the potential to produce low-dose, nontoxic RNAi agents to treat important diseases.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bph62219-cancer-stem.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>BioPharm Reports (VennBio Ltd)</dc:creator>
  <title>Cancer Stem Cells: Emerging Therapeutic, Diagnostic and Market Opportunities (2008)</title>
  <link>http://www.the-infoshop.com/study/bph62219-cancer-stem.html</link>
  <description>This report gives a comprehensive up-to-date review of global R&amp;D on CSCs and strategies to target them. This includes around 30 companies or commercially based research organisations (including 20 SMEs and five major pharmaceutical companies) that are progressing drug discovery activities, including drug pipeline (pre-clinical to Phase III), discovery strategy,</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bph62220-neuropathy.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>BioPharm Reports (VennBio Ltd)</dc:creator>
  <title>Peripheral Neuropathy and Neuropathic Pain, 2008</title>
  <link>http://www.the-infoshop.com/study/bph62220-neuropathy.html</link>
  <description>This report estimates that Peripheral Neuropathy (PN) and Neuropathic Pain (NP) affect 170 to 270 million individuals globally. PN and NP are causally linked to a number of diseases, however diabetes, cancer and HIV alone are expected to increase the prevalence of PN and NP by more than 10% by 2012.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bph62222-drug-resistance.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>BioPharm Reports (VennBio Ltd)</dc:creator>
  <title>Antibiotics and Drug Resistance 2008</title>
  <link>http://www.the-infoshop.com/study/bph62222-drug-resistance.html</link>
  <description>This report reviews new drug innovation and strategy to combat antibiotic resistance mechanisms. This embraces current research-stage activities, patents published in the last five years, the entire pharmaceutical development pipeline and today' s existing armoury of anti-bacterial drugs.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit62969-rnai-mkt-insight.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapy Market Research</dc:subject>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>RNAI - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit62969-rnai-mkt-insight.html</link>
  <description>This Market Insight Report on RNAi covers both products and services in the RNAi industry. The global RNAi market is analyzed by Tools/Products and Applications for each of the geographic regions- United States, Europe , Asia-Pacific and Rest of World. The RNAi Tools/Products are further segmented into Design/Software (miRNA Target Scan, miRNA Analysis Software, and Design Software), Synthesis (Expression Vectors, Chemical, iRNA Isolation, Dicer/RNAseIII, and In Vitro), Delivery (Vector Based, Transfection Reagents, and Electroporation), Monitoring/Optimizing (Primers for RTqPCR, Controls, and miRNA Detection Tools), and Libraries (Human, Mouse, and Rat). Application by Research (Functional Genomics, Metabolism, and Protein Chemistry),</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit63054-herg-screening.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>hERG SCREENING - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit63054-herg-screening.html</link>
  <description>The report provides essential information including market data, segmentation, market size, key trends, M&amp;A, product developments, industry forecasts, corporate intelligence, and other relevant information.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit63056-adme-tox.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>ADME /TOX TECHNOLOGIES - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit63056-adme-tox.html</link>
  <description>This market insight report on ADME/Tox Technologies covers both products and services used in the ADME/TOX industry. Predictive technologies analyzed include In vivo, In vitro, and In silico.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit63057-high-throughput.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>HIGH THROUGHPUT SCREENING- A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit63057-high-throughput.html</link>
  <description>This market insight report presents an in depth analysis of High Throughput Screening (HTS). The study emphasizes on both the technology and product segments of HTS in biotechnology and pharmaceutical application areas.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit63058-biomarkers.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>BIOMARKERS - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit63058-biomarkers.html</link>
  <description>The study provides global market analysis for biomarkers by the above disease areas and also by prominent biomarker discovery technologies including imaging, genomics, proteomics, metabolomics, bioinformatics and other technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic resonance, mass spectrometry/liquid chromatography and nanobiotechnology.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit63059-metabolomics.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>METABOLOMICS - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit63059-metabolomics.html</link>
  <description>This market insight report gives an insight into Metabolomics Technologies - Combined/Integrated Systems, Hardware Systems for metabolic analytics and Software Systems.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit63068-apoptosis.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>APOPTOSIS - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit63068-apoptosis.html</link>
  <description>This market insight report gives an insight into Apoptosis Molecular Pathways - Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators and p53 Modulators.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rit63070-implants.html">
  <dc:language>en</dc:language>
  <dc:subject>Regenerative Medicine Market Research</dc:subject>
  <dc:subject>Biomaterials Market Research</dc:subject>
  <dc:date>2008-01-31</dc:date>
  <dc:creator>RI Technologies</dc:creator>
  <title>BIOLOGICAL IMPLANTS - A MARKET INSIGHT REPORT</title>
  <link>http://www.the-infoshop.com/study/rit63070-implants.html</link>
  <description>Biological Implants report analyzes the market for biological implant procedures. The total biological implants market is analyzed by tissue/muscle; origin, and mode of administration at global level and for each of the geographic regions - North America, Europe, Asia-Pacific and Rest of World.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bc60393-environmental.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-29</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Environmental Markets for Biotechnology</title>
  <link>http://www.the-infoshop.com/study/bc60393-environmental.html</link>
  <description>This study intends to provide a comprehensive and detailed analysis of the current and forecasted market through 2013 for environmental biotechnology products and their use in a variety of waste treatment markets. This study contributes information and data that provide a total picture of the industry presented herein. The study intends to correlate data that has been calculated from many sources, including manufacturers that participate in this market. The objective of this study is to provide a comprehensive look the environmental biotechnology industry with detailed information on manufacturers; application markets; regulations; patents; government, academic and commercial developments; international markets; and innovative end use biofuel products.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bc60394-companion.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-01-29</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>Monoclonal Therapeutics and Companion Diagnostic Products</title>
  <link>http://www.the-infoshop.com/study/bc60394-companion.html</link>
  <description>Our key objective was to present a comprehensive analysis of the current monoclonal antibody market and its future direction.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bf60347-life-scientists.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-28</dc:date>
  <dc:creator>BioInformatics, LLC</dc:creator>
  <title>Marketing to Life Scientists: Capturing Customers' Attention in Applied Markets</title>
  <link>http://www.the-infoshop.com/study/bf60347-life-scientists.html</link>
  <description>This report will examine the trends, needs and purchasing behavior of life scientists in three dynamic markets: molecular diagnostics; agricultural biotech; and biodefense.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/cd60107-molecular-imaging.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2008-01-25</dc:date>
  <dc:creator>Insight Pharma Reports (Formerly CHI Advances Reports)</dc:creator>
  <title>Molecular Imaging in Drug R&amp;D and Medical Practice: Technologies, Applications, Markets</title>
  <link>http://www.the-infoshop.com/study/cd60107-molecular-imaging.html</link>
  <description>The rapidly emerging field of molecular imaging is poised to open new vistas for basic researchers, scientists working in drug discovery and development, and physicians.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs59651-immunochemicals.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-01-21</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Global Immunochemicals Markets</title>
  <link>http://www.the-infoshop.com/study/fs59651-immunochemicals.html</link>
  <description>This research service analyses the market landscape, challenges, drivers, restraints and opportunities for the global immunochemicals market.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs59653-molecular-imaging.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-19</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Molecular Imaging Markets</title>
  <link>http://www.the-infoshop.com/study/fs59653-molecular-imaging.html</link>
  <description>This study explains in detail about the complete molecular imaging markets in Europe with geographic revenues and recommendations.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/sb59572-microrna2008.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapy Market Research</dc:subject>
  <dc:date>2008-01-17</dc:date>
  <dc:creator>Select Biosciences, Ltd.</dc:creator>
  <title>MicroRNA 2008 Market Report</title>
  <link>http://www.the-infoshop.com/study/sb59572-microrna2008.html</link>
  <description>This is the latest MicroRNA Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the MicroRNA Research Marketplace based upon our continuing coverage of this space. This report presents an exhaustive analysis of all the products and services offered by the various vendors into the research market. Select Biosciences proprietary market surveys addressed the qualitative and quantitative trends in the microRNA research market in terms of challenges, opportunities, and quantitative industry metrics- this highly valuable and recently collected dataset is based on an extensive market analysis performed by Select Biosciences Industry Analyst Team- all the raw data and analyses based on the data are presented in the report.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/kt64574-live-licensing.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-17</dc:date>
  <dc:creator>Visiongain</dc:creator>
  <title>Live-Licensing &amp; In-life testing: R&amp;D Processes and Regulation for New Drugs, 2008-2020</title>
  <link>http://www.the-infoshop.com/study/kt64574-live-licensing.html</link>
  <description>This report provides Live-Licensing &amp; In-life testing Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs59050-eu-immunochemistry.html">
  <dc:language>en</dc:language>
  <dc:subject>Antibody Market Research</dc:subject>
  <dc:date>2008-01-10</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>European Immunochemistry Analysers Markets</title>
  <link>http://www.the-infoshop.com/study/fs59050-eu-immunochemistry.html</link>
  <description>This study contains the market trends, revenue forecasts, geographical Analysis, technology trends, geographic trends, end user trends and competitive Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs58989-biopharmaceutical.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-09</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Global Biopharmaceutical Contract Manufacturing Markets</title>
  <link>http://www.the-infoshop.com/study/fs58989-biopharmaceutical.html</link>
  <description>This research service provides revenue and capacity forecasts for biopharmaceutical CMOs globally, by product type and region. It also provides growth drivers, market trends and a cost analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dc60126-stakeholder.html">
  <dc:language>en</dc:language>
  <dc:subject>Gene Therapy Market Research</dc:subject>
  <dc:date>2008-01-09</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Stakeholder Opinions: Alpha 1 Antitrypsin Deficiency</title>
  <link>http://www.the-infoshop.com/study/dc60126-stakeholder.html</link>
  <description>This report provides Alpha 1 Antitrypsin Deficiency Stakeholder Opinions Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fuji58910-dna-diagnostic.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-07</dc:date>
  <dc:creator>Fuji-Keizai U.S.A., Inc.</dc:creator>
  <title>U.S. DNA-Based Diagnostic and Test Market</title>
  <link>http://www.the-infoshop.com/study/fuji58910-dna-diagnostic.html</link>
  <description>This report examines the U.S. market for DNA-based test products that are commercially available today, or will be soon, to screen for disease, confirm a diagnosis in someone with disease symptoms or even determine if you carry a gene that predisposes you to disease - before it causes symptoms.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/wild58808-co-marketing.html">
  <dc:language>en</dc:language>
  <dc:date>2008-01-03</dc:date>
  <dc:creator>CurrentPartnering, a division of Wildwood Ventures Limited</dc:creator>
  <title>Co-promotion and Co-marketing Agreements in Biopharma</title>
  <link>http://www.the-infoshop.com/study/wild58808-co-marketing.html</link>
  <description>The Co-promotion and Co-marketing Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either a right or option to co-promote/market the resultant product of the research collaboration. There are also numerous pure co-promotion/marketing deals whereby the products originator takes on a co-promotion/marketing partner in order to maximize a products presence in the marketplace. Understanding the flexibility of a prospective partner' s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not. This report contains over 500 links to online copies of actual co-promotion and co-marketing contract documents as submitted to the Securities Exchange Commission by biopharma companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner' s flexibility on a wide range of important issues, many of which will have a significant impact on each party' s ability to derive value from the deal.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/rb62226-bioinformatics.html">
  <dc:language>en</dc:language>
  <dc:subject>Genome-based Drug Discovery Market Research</dc:subject>
  <dc:date>2008-01-01</dc:date>
  <dc:creator>Business Insights</dc:creator>
  <title>Innovations in Bioinformatics: Emerging tools for drug discovery and development</title>
  <link>http://www.the-infoshop.com/study/rb62226-bioinformatics.html</link>
  <description>This report examines the bioinformatic tools used to manage high-throughput data from omic technologies, systems biology modelling and biomarker discovery. Knowledge management solutions are reviewed and the provisions of major bioinformatics contributors are highlighted.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti59036-infections.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-31</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Advances in Molecular Diagnostics for Nosocomial Infections</title>
  <link>http://www.the-infoshop.com/study/ti59036-infections.html</link>
  <description>This research service outlines the key developments taking place globally in the field of molecular-based testing for hospital acquired infections.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/ti59065-synthetic-biology.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-31</dc:date>
  <dc:creator>Technical Insights, Inc.</dc:creator>
  <title>Advances in Synthetic Biology</title>
  <link>http://www.the-infoshop.com/study/ti59065-synthetic-biology.html</link>
  <description>This research services offers a comprehensive overview of trends and innovations in synthetic biology.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/sb60568-immunoassays.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-31</dc:date>
  <dc:creator>Select Biosciences, Ltd.</dc:creator>
  <title>Next-Generation Immunoassays: A Market and Technical Analysis of Research Applications 07</title>
  <link>http://www.the-infoshop.com/study/sb60568-immunoassays.html</link>
  <description>The immunoassay assay is undergoing a major makeover. New amplification methods offer the promise to peer deeper into the proteome; new detection methods offer the promise to see clearer; new multiplexing to look faster and more efficiently; and new content to observe farther. These new technologies are addressing significant unmet needs in sensitivity, accuracy, speed, cost and breadth.     This new report details the opportunities and challenges in a market valued at more than $1.1 billion in 2003 and projected to grow to more than $2.2 billion in 2012. The report is based on surveys of researchers and thorough evaluations of more than 70 technologies encompassing novel antibody generation, real-time detection, new amplification methods and multiplexed antibody arrays. The financial projections are based on a 3 by 5 market matrix model encompassing instruments, antibodies and other reagents and consumables across ELISAs, Western blots, immunoprecipitations, antibody arrays and novel antibody characterization methods.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/mrg64510-us-biomaterials.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials Market Research</dc:subject>
  <dc:date>2007-12-31</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>US Markets for Dental Biomaterials 2008</title>
  <link>http://www.the-infoshop.com/study/mrg64510-us-biomaterials.html</link>
  <description>In 2007, the US dental biomaterial market exceeded $100 million in revenues.   This market is comprised of dental bone graft substitutes, dental membranes, and tissue regeneration materials.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/mrg64512-biomaterials.html">
  <dc:language>en</dc:language>
  <dc:subject>Biomaterials Market Research</dc:subject>
  <dc:date>2007-12-31</dc:date>
  <dc:creator>Millennium Research Group</dc:creator>
  <title>European Markets for Dental Biomaterials 2008</title>
  <link>http://www.the-infoshop.com/study/mrg64512-biomaterials.html</link>
  <description>In 2007, the European dental biomaterial market exceeded $140 million.   This market is comprised of dental bone graft substitutes (BGS), tissue regeneration materials, and dental membranes in Germany, France, Italy, Spain, Switzerland, Sweden, and the UK.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/go47247-organs.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-30</dc:date>
  <dc:creator>Global Industry Analysts, Inc.</dc:creator>
  <title>Artificial Organs</title>
  <link>http://www.the-infoshop.com/study/go47247-organs.html</link>
  <description>This report analyzes the worldwide markets for Artificial Organs in US$ Million. The major product segments analyzed are Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas, and Artificial Lungs. Annual forecasts are provided for the period of 2000 through 2010.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/dc58749-autoimmune.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-26</dc:date>
  <dc:creator>Datamonitor</dc:creator>
  <title>Commercial Insight: Autoimmune Overview - Market continues to prosper</title>
  <link>http://www.the-infoshop.com/study/dc58749-autoimmune.html</link>
  <description>This report provides Autoimmune Overview Market Research, Trends, Analysis.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/bc58557-healthcare.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-20</dc:date>
  <dc:creator>BCC Research</dc:creator>
  <title>2007 Healthcare Research Review</title>
  <link>http://www.the-infoshop.com/study/bc58557-healthcare.html</link>
  <description>Advances in healthcare technology have extended the lifetimes and improved the quality of life of millions of people. Global markets for healthcare technology will continue to grow very strongly for the foreseeable future; as other technology markets mature and experience slower growth - or no growth at all - technologies used in healthcare continue to expand at robust rates.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs58497-us-cardiac.html">
  <dc:language>en</dc:language>
  <dc:subject>Immunoassays Market Research </dc:subject>
  <dc:date>2007-12-18</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>U.S. Cardiac Biomarkers Diagnostics Markets</title>
  <link>http://www.the-infoshop.com/study/fs58497-us-cardiac.html</link>
  <description>This research service analyzes the market for cardiac biomarkers within the United States. The United States market was divided into the acute myocardial infarction diagnostics and congestive heart failure diagnostics market segments.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/fs58499-biotechnology.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-18</dc:date>
  <dc:creator>Frost &amp; Sullivan</dc:creator>
  <title>Contract Research Organization Market- What Pharmaceutical and Biotechnology Companies Want</title>
  <link>http://www.the-infoshop.com/study/fs58499-biotechnology.html</link>
  <description>This analysis is available through our Pharmaceuticals &amp; Biotechnology Growth Partnership Service program.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk56795-clinical-chemistry.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-15</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Clinical Chemistry Analyzers</title>
  <link>http://www.the-infoshop.com/study/tk56795-clinical-chemistry.html</link>
  <description>Clinical chemistry analysis is one of the most important areas within clinical laboratory analysis. The term clinical chemistry usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily-collected bodily fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations.</description>
</item>
<item rdf:about="http://www.the-infoshop.com/study/tk58612-clinical-immun.html">
  <dc:language>en</dc:language>
  <dc:date>2007-12-15</dc:date>
  <dc:creator>Trimark Publications</dc:creator>
  <title>Clinical Immunoanalyzer Markets</title>
  <link>http://www.the-infoshop.com/study/tk58612-clinical-immun.html</link>
  <description>Clinical immunoanalyzer analysis is one of the most important functions of clinical laboratory analysis. By all accounts, automated immunoassay testing is the most rapidly developing of the traditional clinical laboratory sectors. Clinical immunoanalyzer analysis usually refers to determining the concentration or activity of protein, carbohydrate, lipid, enzyme or small molecule in easily collected body fluids, such as blood, serum, plasma or urine. However, it is not necessarily limited to these purposes. The analysis of virtually any biologically active substance in any p